cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Baxter International Inc
19 own
24 watching
Current Price
$39.47
$-0.18
(-0.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
20,911.27M
52-Week High
52-Week High
50.21000
52-Week Low
52-Week Low
31.01000
Average Volume
Average Volume
2.81M
Dividend Yield
Dividend Yield
0.013455
P/E Ratio
P/E Ratio
32.5274
iconMarket Capitalization20,911.27M
icon52-Week High50.21000
icon52-Week Low31.01000
iconAverage Volume2.81M
iconDividend Yield0.013455
iconP/E Ratio32.5274
What does the Baxter International Inc do?
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Read More
How much money does Baxter International Inc make?
News & Events about Baxter International Inc.
Business Wire
9 months ago
Baxter International Inc. (NYSE:BAX), an innovator in connected beds for med-surg and the intensive care unit (ICU), announced today the U.S. launch of its new Hillrom Progressa+ bed for the ICU...
Business Wire
10 months ago
Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2022 Corporate Responsibility Report. The annual report, which features performance updates on the companys 2030 Corporate Responsibility Commitment and Goals, demonstrates Baxters steadfast commitment to operating...
PR Newswire
10 months ago
BAX FRAUD ALERT: Jakubowitz Law is Investigating Baxter International Inc. in Connection with Potential Violations of Federal Securities Laws BAX FRAUD ALERT: Jakubowitz Law is Investigating Baxter International Inc. in Connection with Potential Violations of Federal Securities Laws PR Newswire NEW...
PR Newswire
10 months ago
BAX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Baxter International Inc. BAX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities...
PR Newswire
10 months ago
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Baxter International Inc. of an Investigation and Potential Class Action Lawsuit - (NYSE: BAX) INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Baxter International Inc. of an Investigation and Potential Class Action...
Frequently Asked Questions
Frequently Asked Questions
What is Baxter International Inc share price today?
plus_minus_icon
Can Indians buy Baxter International Inc shares?
plus_minus_icon
How can I buy Baxter International Inc shares from India?
plus_minus_icon
Can Fractional shares of Baxter International Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Baxter International Inc stocks?
plus_minus_icon
What is today’s traded volume of Baxter International Inc?
plus_minus_icon
What is today’s market capitalisation of Baxter International Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Baxter International Inc?
plus_minus_icon
What percentage is Baxter International Inc down from its 52-Week High?
plus_minus_icon
What percentage is Baxter International Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$39.47
$-0.18
(-0.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00